{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:35:40Z","timestamp":1763058940558,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ek0109490h0003","JP22gm4010013"],"award-info":[{"award-number":["JP22ek0109490h0003","JP22gm4010013"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016730","name":"Torii Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JPMJST2181","JP15H05721","JP20K17509","JP21H05042","JP22K20710"],"award-info":[{"award-number":["JPMJST2181","JP15H05721","JP20K17509","JP21H05042","JP22K20710"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtn.2023.07.011","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:06:01Z","timestamp":1689595561000},"page":"404-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Branchpoints as potential targets of exon-skipping therapies for genetic disorders"],"prefix":"10.1016","volume":"33","author":[{"given":"Hiroaki","family":"Ohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-3172","authenticated-orcid":false,"given":"Tomonari","family":"Awaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiya","family":"Sako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.07.011_bib1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","volume":"136","author":"Vaz-Drago","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2023.07.011_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00439-022-02485-2","article-title":"RNA-seq analysis, targeted long-read sequencing and in\u00a0silico prediction to unravel pathogenic intronic events and complicated splicing abnormalities in dystrophinopathy","volume":"142","author":"Okubo","year":"2023","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2023.07.011_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0387-7604(81)80002-2","article-title":"Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations","volume":"3","author":"Fukuyama","year":"1981","journal-title":"Brain Dev."},{"key":"10.1016\/j.omtn.2023.07.011_bib4","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy","volume":"14","author":"Kanagawa","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2023.07.011_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(02)11397-3","article-title":"Defective glycosylation in muscular dystrophy","volume":"360","author":"Muntoni","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2023.07.011_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nmd.2010.06.005","article-title":"Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea","volume":"20","author":"Lim","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2023.07.011_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/jhg.2017.71","article-title":"Deep-intronic variant of fukutin is the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan","volume":"62","author":"Kobayashi","year":"2017","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtn.2023.07.011_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(83)90432-4","article-title":"The U1 small nuclear RNA-protein complex selectively binds a 5' splice site in\u00a0vitro","volume":"33","author":"Mount","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.07.011_bib9","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1073\/pnas.86.23.9243","article-title":"Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor","volume":"86","author":"Zamore","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.07.011_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(88)90509-0","article-title":"A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly","volume":"52","author":"Ruskin","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.07.011_bib11","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1128\/MCB.24.24.10505-10514.2004","article-title":"Influence of RNA secondary structure on the pre-mRNA splicing process","volume":"24","author":"Buratti","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib12","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.07.011_bib13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.chembiol.2020.08.013","article-title":"Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion","volume":"27","author":"Shibata","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ncomms1306","article-title":"Chemical treatment enhances skipping of a mutated exon in the dystrophin gene","volume":"2","author":"Nishida","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.07.011_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep46126","article-title":"Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy","volume":"7","author":"Sako","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.07.011_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI124011","article-title":"Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency","volume":"129","author":"Boisson","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2023.07.011_bib17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1261\/rna.065383.117","article-title":"Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping","volume":"24","author":"Wu","year":"2018","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2023.07.011_bib18","doi-asserted-by":"crossref","first-page":"24246","DOI":"10.1074\/jbc.M314298200","article-title":"Manipulation of alternative splicing by a newly developed inhibitor of Clks","volume":"279","author":"Muraki","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.07.011_bib19","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1073\/pnas.1415525112","article-title":"Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia","volume":"112","author":"Yoshida","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.07.011_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/cb100248e","article-title":"Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product","volume":"6","author":"Hasegawa","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nchembio.2007.18","article-title":"Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA","volume":"3","author":"Kaida","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/tpj.13383","article-title":"Pre-mRNA splicing repression triggers abiotic stress signaling in plants","volume":"89","author":"Ling","year":"2017","journal-title":"Plant J."},{"key":"10.1016\/j.omtn.2023.07.011_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/bioinformatics\/btx688","article-title":"Machine learning annotation of human branchpoints","volume":"34","author":"Signal","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2023.07.011_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001016","article-title":"Genome-wide association between branch point properties and alternative splicing","volume":"6","author":"Corvelo","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.omtn.2023.07.011_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gr.182899.114","article-title":"Genome-wide discovery of human splicing branchpoints","volume":"25","author":"Mercer","year":"2015","journal-title":"Genome Res."},{"key":"10.1016\/j.omtn.2023.07.011_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature10456","article-title":"Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy","volume":"478","author":"Taniguchi-Ikeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.07.011_bib28","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/humu.24074","article-title":"Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars","volume":"41","author":"Canson","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2023.07.011_bib29","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1109\/ACCESS.2018.2886569","article-title":"Branch Point Selection in RNA Splicing Using Deep Learning","volume":"7","author":"Nazari","year":"2019","journal-title":"IEEE Access"},{"key":"10.1016\/j.omtn.2023.07.011_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2023.07.011_bib31","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2023.07.011_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2023.07.011_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mus.27347","article-title":"Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double-blind, placebo-controlled, dose-titration trial","volume":"64","author":"Wagner","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2023.07.011_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/nat.2020.0921","article-title":"Transcriptome-Wide Off-Target Effects of Steric-Blocking Oligonucleotides","volume":"31","author":"Holgersen","year":"2021","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2023.07.011_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.omtn.2018.09.017","article-title":"NS-065\/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy","volume":"13","author":"Watanabe","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.07.011_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.stemcr.2020.08.010","article-title":"Identification of Qk as a Glial Precursor Cell Marker that Governs the Fate Specification of Neural Stem Cells to a Glial Cell Lineage","volume":"15","author":"Takeuchi","year":"2020","journal-title":"Stem Cell Rep."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123001828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:39:32Z","timestamp":1761874772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"alternative-id":["S2162253123001828"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.07.011","relation":{},"ISSN":["2162-2531"],"issn-type":[{"type":"print","value":"2162-2531"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Branchpoints as potential targets of exon-skipping therapies for genetic disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}